Parathyroid hormone regulates the expression of rat osteoblast and osteosarcoma nuclear matrix proteins

Joseph Bidwell, Hilary Feister, Darl Swartz, Jude Onyia, Joseph Holden, Janet Hock

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Parathyroid hormone (PTH) alters osteoblast morphology. How these changes in cell shape modify nuclear structure and ultimately gene expression is not known. Chronic exposure to rat PTH (1-34) [10 nM] attenuated the expression of 200, 190, and 160 kD proteins in the nuclear matrix- intermediate filament subfraction of the rat osteosarcoma cells, ROS 17/2.8 [Bidwell et al. (1994b): Endocrinology 134:1738-1744]. Here, we determined that these same PTH-responsive proteins were expressed in rat metaphyseal osteoblasts. We identified the 200 kD protein as a non-muscle myosin. Although the molecular weights, subcellular distribution, and half-lives of the 190 and 180 kD proteins were similar to topoisomerase II-α and -β, nuclear matrix enzymes that mediate DNA topology, the 190 and 160 kD proteins did not interact with topoisomerase antibodies. Nevertheless, the expression of topoisomerase II-α, and NuMA, a component of the nuclear core filaments, was also regulated by PTH in the osteosarcoma cells. The 190 kD protein was selectively expressed in bone cells as it was not observed in OK opossum kidney cells, H4 hepatoma cells, or NIH3T3 cells. PTH attenuated mRNA expression of the PTH receptor in our cell preparations. These results demonstrate that PTH selectively alters the expression of osteoblast membrane, cytoskeletal, and nucleoskeletal proteins. Topoisomerase II-α, NuMA, and the 190 and 160 kD proteins may direct the nuclear PTH signalling pathways to the target genes and play a structural role in osteoblast gene expression.

Original languageEnglish
Pages (from-to)374-383
Number of pages10
JournalJournal of Cellular Biochemistry
Volume63
Issue number3
DOIs
StatePublished - Dec 1 1996

Fingerprint

Nuclear Matrix-Associated Proteins
Osteoblasts
Osteosarcoma
Parathyroid Hormone
Rats
Type II DNA Topoisomerase
Proteins
Cell Nucleus Shape
Gene expression
Parathyroid Hormone Receptor Type 1
Endocrinology
Gene Expression
Nuclear Matrix
Opossums
Cytoskeletal Proteins
Intermediate Filaments
Myosins
Molecular weight distribution
Hepatocellular Carcinoma
Molecular Weight

Keywords

  • NuMA
  • primary spongiosa
  • PTH-induced downregulation
  • tissue matrix
  • topoisomerase

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology

Cite this

Parathyroid hormone regulates the expression of rat osteoblast and osteosarcoma nuclear matrix proteins. / Bidwell, Joseph; Feister, Hilary; Swartz, Darl; Onyia, Jude; Holden, Joseph; Hock, Janet.

In: Journal of Cellular Biochemistry, Vol. 63, No. 3, 01.12.1996, p. 374-383.

Research output: Contribution to journalArticle

Bidwell, Joseph ; Feister, Hilary ; Swartz, Darl ; Onyia, Jude ; Holden, Joseph ; Hock, Janet. / Parathyroid hormone regulates the expression of rat osteoblast and osteosarcoma nuclear matrix proteins. In: Journal of Cellular Biochemistry. 1996 ; Vol. 63, No. 3. pp. 374-383.
@article{e340f5838d7c4f789203042646b31824,
title = "Parathyroid hormone regulates the expression of rat osteoblast and osteosarcoma nuclear matrix proteins",
abstract = "Parathyroid hormone (PTH) alters osteoblast morphology. How these changes in cell shape modify nuclear structure and ultimately gene expression is not known. Chronic exposure to rat PTH (1-34) [10 nM] attenuated the expression of 200, 190, and 160 kD proteins in the nuclear matrix- intermediate filament subfraction of the rat osteosarcoma cells, ROS 17/2.8 [Bidwell et al. (1994b): Endocrinology 134:1738-1744]. Here, we determined that these same PTH-responsive proteins were expressed in rat metaphyseal osteoblasts. We identified the 200 kD protein as a non-muscle myosin. Although the molecular weights, subcellular distribution, and half-lives of the 190 and 180 kD proteins were similar to topoisomerase II-α and -β, nuclear matrix enzymes that mediate DNA topology, the 190 and 160 kD proteins did not interact with topoisomerase antibodies. Nevertheless, the expression of topoisomerase II-α, and NuMA, a component of the nuclear core filaments, was also regulated by PTH in the osteosarcoma cells. The 190 kD protein was selectively expressed in bone cells as it was not observed in OK opossum kidney cells, H4 hepatoma cells, or NIH3T3 cells. PTH attenuated mRNA expression of the PTH receptor in our cell preparations. These results demonstrate that PTH selectively alters the expression of osteoblast membrane, cytoskeletal, and nucleoskeletal proteins. Topoisomerase II-α, NuMA, and the 190 and 160 kD proteins may direct the nuclear PTH signalling pathways to the target genes and play a structural role in osteoblast gene expression.",
keywords = "NuMA, primary spongiosa, PTH-induced downregulation, tissue matrix, topoisomerase",
author = "Joseph Bidwell and Hilary Feister and Darl Swartz and Jude Onyia and Joseph Holden and Janet Hock",
year = "1996",
month = "12",
day = "1",
doi = "10.1002/(SICI)1097-4644(19961201)63:3<374::AID-JCB13>3.0.CO;2-H",
language = "English",
volume = "63",
pages = "374--383",
journal = "Journal of Cellular Biochemistry",
issn = "0730-2312",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Parathyroid hormone regulates the expression of rat osteoblast and osteosarcoma nuclear matrix proteins

AU - Bidwell, Joseph

AU - Feister, Hilary

AU - Swartz, Darl

AU - Onyia, Jude

AU - Holden, Joseph

AU - Hock, Janet

PY - 1996/12/1

Y1 - 1996/12/1

N2 - Parathyroid hormone (PTH) alters osteoblast morphology. How these changes in cell shape modify nuclear structure and ultimately gene expression is not known. Chronic exposure to rat PTH (1-34) [10 nM] attenuated the expression of 200, 190, and 160 kD proteins in the nuclear matrix- intermediate filament subfraction of the rat osteosarcoma cells, ROS 17/2.8 [Bidwell et al. (1994b): Endocrinology 134:1738-1744]. Here, we determined that these same PTH-responsive proteins were expressed in rat metaphyseal osteoblasts. We identified the 200 kD protein as a non-muscle myosin. Although the molecular weights, subcellular distribution, and half-lives of the 190 and 180 kD proteins were similar to topoisomerase II-α and -β, nuclear matrix enzymes that mediate DNA topology, the 190 and 160 kD proteins did not interact with topoisomerase antibodies. Nevertheless, the expression of topoisomerase II-α, and NuMA, a component of the nuclear core filaments, was also regulated by PTH in the osteosarcoma cells. The 190 kD protein was selectively expressed in bone cells as it was not observed in OK opossum kidney cells, H4 hepatoma cells, or NIH3T3 cells. PTH attenuated mRNA expression of the PTH receptor in our cell preparations. These results demonstrate that PTH selectively alters the expression of osteoblast membrane, cytoskeletal, and nucleoskeletal proteins. Topoisomerase II-α, NuMA, and the 190 and 160 kD proteins may direct the nuclear PTH signalling pathways to the target genes and play a structural role in osteoblast gene expression.

AB - Parathyroid hormone (PTH) alters osteoblast morphology. How these changes in cell shape modify nuclear structure and ultimately gene expression is not known. Chronic exposure to rat PTH (1-34) [10 nM] attenuated the expression of 200, 190, and 160 kD proteins in the nuclear matrix- intermediate filament subfraction of the rat osteosarcoma cells, ROS 17/2.8 [Bidwell et al. (1994b): Endocrinology 134:1738-1744]. Here, we determined that these same PTH-responsive proteins were expressed in rat metaphyseal osteoblasts. We identified the 200 kD protein as a non-muscle myosin. Although the molecular weights, subcellular distribution, and half-lives of the 190 and 180 kD proteins were similar to topoisomerase II-α and -β, nuclear matrix enzymes that mediate DNA topology, the 190 and 160 kD proteins did not interact with topoisomerase antibodies. Nevertheless, the expression of topoisomerase II-α, and NuMA, a component of the nuclear core filaments, was also regulated by PTH in the osteosarcoma cells. The 190 kD protein was selectively expressed in bone cells as it was not observed in OK opossum kidney cells, H4 hepatoma cells, or NIH3T3 cells. PTH attenuated mRNA expression of the PTH receptor in our cell preparations. These results demonstrate that PTH selectively alters the expression of osteoblast membrane, cytoskeletal, and nucleoskeletal proteins. Topoisomerase II-α, NuMA, and the 190 and 160 kD proteins may direct the nuclear PTH signalling pathways to the target genes and play a structural role in osteoblast gene expression.

KW - NuMA

KW - primary spongiosa

KW - PTH-induced downregulation

KW - tissue matrix

KW - topoisomerase

UR - http://www.scopus.com/inward/record.url?scp=0029851257&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029851257&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-4644(19961201)63:3<374::AID-JCB13>3.0.CO;2-H

DO - 10.1002/(SICI)1097-4644(19961201)63:3<374::AID-JCB13>3.0.CO;2-H

M3 - Article

C2 - 8913889

AN - SCOPUS:0029851257

VL - 63

SP - 374

EP - 383

JO - Journal of Cellular Biochemistry

JF - Journal of Cellular Biochemistry

SN - 0730-2312

IS - 3

ER -